These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7526789)

  • 1. Interferon therapy for the anti-HBe positive form of chronic hepatitis B.
    Alberti A; Fattovich G
    Antiviral Res; 1994 Jul; 24(2-3):145-53. PubMed ID: 7526789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B.
    Zhang X; Zoulim F; Habersetzer F; Xiong S; Trépo C
    J Med Virol; 1996 Jan; 48(1):8-16. PubMed ID: 8825704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection.
    Marinos G; Smith HM; Naoumov NV; Williams R
    Hepatology; 1994 Feb; 19(2):303-11. PubMed ID: 8294088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.
    Brunetto MR; Giarin MM; Oliveri F; Chiaberge E; Baldi M; Alfarano A; Serra A; Saracco G; Verme G; Will H
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4186-90. PubMed ID: 2034663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus precore mutations and HBeAg negative reactivation of chronic hepatitis B after interferon therapy.
    Talbodec N; Loriot MA; Gigou M; Guigonis V; Boyer N; Bezeaud A; Erlinger S; Benhamou JP; Marcellin P
    Liver; 1995 Apr; 15(2):93-8. PubMed ID: 7540713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low level wild-type and pre-core mutant hepatitis B viruses and HBeAg negative reactivation of chronic hepatitis B.
    Oketani M; Oketani K; Xiaohong C; Arima T
    J Med Virol; 1999 Aug; 58(4):332-7. PubMed ID: 10421398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.
    Hadziyannis SJ; Lieberman HM; Karvountzis GG; Shafritz DA
    Hepatology; 1983; 3(5):656-62. PubMed ID: 6618432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus precore/core variation and interferon therapy.
    Fattovich G; McIntyre G; Thursz M; Colman K; Giuliano G; Alberti A; Thomas HC; Carman WF
    Hepatology; 1995 Nov; 22(5):1355-62. PubMed ID: 7590647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment.
    Günther S; Meisel H; Reip A; Miska S; Krüger DH; Will H
    Virology; 1992 Mar; 187(1):271-9. PubMed ID: 1736529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precore mutant hepatitis B virus and outcome of chronic infection and hepatitis in hepatitis B e antigen-positive children.
    Barbera C; Calvo P; Coscia A; Perugini L; Dastoli G; Randone A; Bonino F; Brunetto MR
    Pediatr Res; 1994 Sep; 36(3):347-50. PubMed ID: 7528908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region.
    Tong SP; Li JS; Vitvitski L; Trépo C
    Virology; 1990 Jun; 176(2):596-603. PubMed ID: 2345966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis.
    Schepis F; Verucchi G; Pollicino T; Attard L; Brancatelli S; Longo G; Raimondo G
    J Hepatol; 1997 Apr; 26(4):765-70. PubMed ID: 9126787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiquantitative anti-HBc IgM detection in children with chronic hepatitis B: a long-term follow-up study.
    Gaeta GB; Nardiello S; Pizzella T; Russo G; Maisto A; Sardaro C; Galanti B; Giusti G
    J Med Virol; 1995 Jul; 46(3):173-7. PubMed ID: 7561786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers.
    Fujiwara K; Yokosuka O; Ehata T; Chuang WL; Imazeki F; Saisho H; Omata M
    Dig Dis Sci; 1998 Feb; 43(2):368-76. PubMed ID: 9512133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of wild-type and precore mutant HBV infection after liver transplantation.
    Torre F; Wong PY; Macartney M; Williams R; Naoumov NV
    J Med Virol; 1999 Sep; 59(1):5-13. PubMed ID: 10440801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBV pre-core mutant in genotype-D infected children is selected during HBeAg/anti-HBe seroconversion and leads to HBeAg negative chronic hepatitis B in adulthood.
    Colombatto P; Barbera C; Bortolotti F; Maina AM; Moriconi F; Cavallone D; Calvo P; Oliveri F; Bonino F; Brunetto MR
    J Med Virol; 2018 Jul; 90(7):1232-1239. PubMed ID: 29488227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.